NanoCarrier Co., Ltd. (4571.T)
JPY 150.0
(-1.96%)
JPY 150.0
(-1.96%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 184 Thousand JPY | -71.6% |
| 2022 | 648 Thousand JPY | -98.06% |
| 2021 | 33.4 Million JPY | -75.85% |
| 2020 | 138.32 Million JPY | 81.67% |
| 2019 | 76.14 Million JPY | 131.81% |
| 2018 | 32.84 Million JPY | -78.35% |
| 2017 | 151.72 Million JPY | -44.99% |
| 2016 | 275.8 Million JPY | 84.13% |
| 2015 | 149.79 Million JPY | 191.42% |
| 2014 | 51.4 Million JPY | -74.62% |
| 2013 | 202.56 Million JPY | 12.09% |
| 2012 | 180.71 Million JPY | 82.57% |
| 2011 | 98.98 Million JPY | 45.78% |
| 2010 | 67.89 Million JPY | 207.67% |
| 2009 | 22.06 Million JPY | 93.05% |
| 2008 | 11.43 Million JPY | -90.57% |
| 2007 | 121.16 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 184 Thousand JPY | -100.0% |
| 2023 Q3 | 3.02 Million JPY | 35.84% |
| 2023 FY | 184 Thousand JPY | -71.6% |
| 2023 Q4 | 184 Thousand JPY | -93.91% |
| 2023 Q1 | 1.19 Million JPY | 84.72% |
| 2023 Q2 | 2.22 Million JPY | 85.8% |
| 2022 Q4 | 648 Thousand JPY | 95.77% |
| 2022 Q3 | 331 Thousand JPY | -73.37% |
| 2022 FY | 648 Thousand JPY | -98.06% |
| 2022 Q1 | 1.35 Million JPY | -95.95% |
| 2022 Q2 | 1.24 Million JPY | -8.13% |
| 2021 Q2 | 188.73 Million JPY | 28.81% |
| 2021 Q4 | 33.4 Million JPY | -55.9% |
| 2021 FY | 33.4 Million JPY | -75.85% |
| 2021 Q1 | 146.52 Million JPY | 5.93% |
| 2021 Q3 | 75.75 Million JPY | -59.86% |
| 2020 FY | 138.32 Million JPY | 81.67% |
| 2020 Q1 | 184.94 Million JPY | 142.89% |
| 2020 Q2 | 136.35 Million JPY | -26.27% |
| 2020 Q3 | 148.98 Million JPY | 9.26% |
| 2020 Q4 | 138.32 Million JPY | -7.16% |
| 2019 Q1 | 49.19 Million JPY | 49.76% |
| 2019 Q3 | 50.43 Million JPY | 19.53% |
| 2019 Q4 | 76.14 Million JPY | 50.96% |
| 2019 FY | 76.14 Million JPY | 131.81% |
| 2019 Q2 | 42.19 Million JPY | -14.22% |
| 2018 Q1 | 112.17 Million JPY | -26.07% |
| 2018 Q3 | 27.93 Million JPY | -76.33% |
| 2018 Q4 | 32.84 Million JPY | 17.58% |
| 2018 FY | 32.84 Million JPY | -78.35% |
| 2018 Q2 | 117.99 Million JPY | 5.19% |
| 2017 Q2 | 130.66 Million JPY | -32.52% |
| 2017 Q4 | 151.72 Million JPY | -27.62% |
| 2017 FY | 151.72 Million JPY | -44.99% |
| 2017 Q1 | 193.62 Million JPY | -29.8% |
| 2017 Q3 | 209.63 Million JPY | 60.44% |
| 2016 Q3 | 281.92 Million JPY | -6.7% |
| 2016 FY | 275.8 Million JPY | 84.13% |
| 2016 Q1 | 253.98 Million JPY | 69.56% |
| 2016 Q4 | 275.8 Million JPY | -2.17% |
| 2016 Q2 | 302.16 Million JPY | 18.97% |
| 2015 Q2 | 88.97 Million JPY | 116.63% |
| 2015 Q1 | 41.07 Million JPY | -20.09% |
| 2015 FY | 149.79 Million JPY | 191.42% |
| 2015 Q3 | 91.12 Million JPY | 2.41% |
| 2015 Q4 | 149.79 Million JPY | 64.39% |
| 2014 Q4 | 51.4 Million JPY | -58.09% |
| 2014 Q3 | 122.65 Million JPY | -26.94% |
| 2014 FY | 51.4 Million JPY | -74.62% |
| 2014 Q1 | 173.59 Million JPY | -14.3% |
| 2014 Q2 | 167.88 Million JPY | -3.29% |
| 2013 Q1 | 165.38 Million JPY | -8.48% |
| 2013 FY | 202.56 Million JPY | 12.09% |
| 2013 Q2 | 117.02 Million JPY | -29.25% |
| 2013 Q3 | 193.28 Million JPY | 65.17% |
| 2013 Q4 | 202.56 Million JPY | 4.8% |
| 2012 FY | 180.71 Million JPY | 82.57% |
| 2012 Q1 | 153.76 Million JPY | 55.34% |
| 2012 Q2 | 208.51 Million JPY | 35.61% |
| 2012 Q3 | 208.81 Million JPY | 0.14% |
| 2012 Q4 | 180.71 Million JPY | -13.46% |
| 2011 Q4 | 98.98 Million JPY | 16.39% |
| 2011 Q3 | 85.04 Million JPY | 9.48% |
| 2011 Q1 | 85.02 Million JPY | 25.23% |
| 2011 FY | 98.98 Million JPY | 45.78% |
| 2011 Q2 | 77.68 Million JPY | -8.64% |
| 2010 Q2 | 68.45 Million JPY | 42.48% |
| 2010 Q3 | 80.77 Million JPY | 18.01% |
| 2010 Q4 | 67.89 Million JPY | -15.95% |
| 2010 Q1 | 48.04 Million JPY | 117.7% |
| 2010 FY | 67.89 Million JPY | 207.67% |
| 2009 FY | 22.06 Million JPY | 93.05% |
| 2009 Q3 | 7.08 Million JPY | 0.0% |
| 2009 Q4 | 22.06 Million JPY | 211.47% |
| 2008 Q3 | 12.62 Million JPY | 0.0% |
| 2008 FY | 11.43 Million JPY | -90.57% |
| 2008 Q4 | 11.43 Million JPY | -9.49% |
| 2007 FY | 121.16 Million JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 99.973% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | 98.974% |
| GNI Group Ltd. | 2.33 Billion JPY | 99.992% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 99.992% |
| MEDINET Co., Ltd. | 67.48 Million JPY | 99.727% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 99.984% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 99.822% |
| AnGes, Inc. | 1.61 Billion JPY | 99.989% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | 99.751% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 99.994% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 99.943% |
| Carna Biosciences, Inc. | 140.14 Million JPY | 99.869% |
| CanBas Co., Ltd. | 728 Thousand JPY | 74.725% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | 99.791% |
| RaQualia Pharma Inc. | 147.93 Million JPY | 99.876% |
| Chiome Bioscience Inc. | 64.1 Million JPY | 99.713% |
| Kidswell Bio Corporation | 875.65 Million JPY | 99.979% |
| PeptiDream Inc. | 2.4 Billion JPY | 99.992% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | 96.556% |
| Ribomic Inc. | 2.27 Million JPY | 91.909% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -18399900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | 99.489% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | 99.366% |
| CellSource Co., Ltd. | 305.92 Million JPY | 99.94% |
| FunPep Company Limited | 25.54 Million JPY | 99.28% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 99.949% |
| Stella Pharma Corporation | 1.11 Billion JPY | 99.984% |
| TMS Co., Ltd. | 50.02 Million JPY | 99.632% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | 99.12% |
| Cuorips Inc. | 1.04 Million JPY | 82.359% |
| K Pharma,Inc. | 10.79 Million JPY | 98.295% |
| Takara Bio Inc. | 11.85 Billion JPY | 99.998% |
| ReproCELL Incorporated | 248.14 Million JPY | 99.926% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 99.959% |
| StemCell Institute Inc. | 42.26 Million JPY | 99.565% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 99.919% |
| CellSeed Inc. | 46.19 Million JPY | 99.602% |